Literature DB >> 29652420

Bivalirudin bewilderment.

Behnood Bikdeli1, Gregg W Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29652420      PMCID： PMC5967624          DOI： 10.5603/KP.2018.0074

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  14 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

2.  Bivalirudin started during emergency transport for primary PCI.

Authors:  Philippe Gabriel Steg; Arnoud van 't Hof; Christian W Hamm; Peter Clemmensen; Frédéric Lapostolle; Pierre Coste; Jurrien Ten Berg; Pierre Van Grunsven; Gerrit Jan Eggink; Lutz Nibbe; Uwe Zeymer; Marco Campo dell' Orto; Holger Nef; Jacob Steinmetz; Louis Soulat; Kurt Huber; Efthymios N Deliargyris; Debra Bernstein; Diana Schuette; Jayne Prats; Tim Clayton; Stuart Pocock; Martial Hamon; Patrick Goldstein
Journal:  N Engl J Med       Date:  2013-10-30       Impact factor: 91.245

Review 3.  Most important outcomes research papers on anticoagulation for cardiovascular disease.

Authors:  Behnood Bikdeli; Aakriti Gupta; Purav Mody; Julianna F Lampropulos; Kumar Dharmarajan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-09-01

4.  Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial).

Authors:  Guido Parodi; Angela Migliorini; Renato Valenti; Benedetta Bellandi; Umberto Signorini; Guia Moschi; Piergiovanni Buonamici; Giampaolo Cerisano; David Antoniucci
Journal:  Am J Cardiol       Date:  2010-02-20       Impact factor: 2.778

5.  Procedural Anticoagulation in Myocardial Infarction.

Authors:  Gregg W Stone
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 6.  Risk of Stent Thrombosis and Major Bleeding with Bivalirudin Compared with Active Control: A Systematic Review and Meta-analysis of Randomized Trials.

Authors:  Sina Kianoush; Behnood Bikdeli; Mayur M Desai; John W Eikelboom
Journal:  Thromb Res       Date:  2015-06-06       Impact factor: 3.944

7.  Bivalirudin for patients with acute coronary syndromes.

Authors:  Gregg W Stone; Brent T McLaurin; David A Cox; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Harvey D White; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Philip E Aylward; Angel R Cequier; Harald Darius; Walter Desmet; Ramin Ebrahimi; Martial Hamon; Lars H Rasmussen; Hans-Jürgen Rupprecht; James Hoekstra; Roxana Mehran; E Magnus Ohman
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

8.  Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Authors:  Yaling Han; Jincheng Guo; Yang Zheng; Hongyun Zang; Xi Su; Yu Wang; Shaoliang Chen; Tiemin Jiang; Ping Yang; Jiyan Chen; Dongju Jiang; Quanmin Jing; Zhenyang Liang; Haiwei Liu; Xin Zhao; Jing Li; Yi Li; Bo Xu; Gregg W Stone
Journal:  JAMA       Date:  2015-04-07       Impact factor: 56.272

Review 9.  Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.

Authors:  Raphaelle Dumaine; Maria Borentain; Osmund Bertel; Christoph Bode; Richard Gallo; Harvey D White; Jean-Philippe Collet; Steven R Steinhubl; Gilles Montalescot
Journal:  Arch Intern Med       Date:  2007-12-10

10.  Bivalirudin during primary PCI in acute myocardial infarction.

Authors:  Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran
Journal:  N Engl J Med       Date:  2008-05-22       Impact factor: 91.245
View more
  1 in total

1.  Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology.

Authors:  Behnood Bikdeli; Thomas McAndrew; Aaron Crowley; Shmuel Chen; Ghazaleh Mehdipoor; Björn Redfors; Yangbo Liu; Zixuan Zhang; Mengdan Liu; Yiran Zhang; Dominic P Francese; David Erlinge; Stefan K James; Yaling Han; Yi Li; Adnan Kastrati; Stefanie Schüpke; Rod H Stables; Adeel Shahzad; Philippe Gabriel Steg; Patrick Goldstein; Enrico Frigoli; Roxana Mehran; Marco Valgimigli; Gregg W Stone
Journal:  Thromb Haemost       Date:  2019-12-09       Impact factor: 5.249
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.